Lacto-vegetarian diet with 14-hour fasting improves diabetes control in women

In a 24-week trial conducted across clinics in Pune, India, researchers tested whether a combination of two dietary approaches could help women with type 2 diabetes regain metabolic control. The intervention was straightforward: eat a lacto-vegetarian diet—one that draws protein and calcium from dairy while building meals around plants—and compress all eating into a 10-hour window each day, fasting for the remaining 14 hours. By the end of the study, the results were striking enough to suggest that this pairing deserves serious attention as a treatment option tailored specifically to women's lives.

Type 2 diabetes hits women differently than men, and the reasons are woven into the texture of daily life. Women carry a disproportionate load of caregiving—for children, aging parents, households—which leaves less time for the dietary planning and self-monitoring that diabetes management demands. Hormonal shifts across the lifespan alter how the body stores fat and responds to insulin. A history of gestational diabetes multiplies the risk of developing type 2 diabetes sevenfold or more. Stress, depression, and anxiety, all more common among women, trigger inflammatory pathways that worsen blood sugar control. The researchers designing this trial understood that a treatment plan asking women to fast for 16 hours or count calories obsessively would likely fail. They needed something sustainable, something that fit into the reality of Indian women's lives.

The lacto-vegetarian diet offered cultural familiarity and metabolic promise. Plant-based eating delivers fiber, antioxidants, and phytochemicals in a relatively low-calorie package, with minimal saturated fat. Add dairy—milk, yogurt, cheese—and you gain high-quality protein and calcium without abandoning the plant-forward foundation. The 14-hour fasting window, meanwhile, had shown promise in earlier research as more tolerable than the popular 16:8 protocol, which asks people to fast for 16 hours and eat within 8. The 14:10 approach (14 hours fasting, 10 hours eating) retained metabolic benefits while proving easier to stick with.

The trial enrolled 96 women aged 25 to 60, all with at least a year of type 2 diabetes diagnosis and stable medication for at least three months. Ninety completed the full 24 weeks. Half received the combined intervention—the lacto-vegetarian diet structured to provide 15 to 20 percent of calories from protein, 20 to 25 percent from fat, and 50 to 55 percent from carbohydrates, mostly whole grains and high-fiber foods. They also received individualized meal planning from a nutritionist, regular check-ins, photo monitoring of meals, and telephone support. The other half continued their usual diabetes care.

The metabolic shifts were substantial. In the intervention group, HbA1c—the three-month average of blood glucose—fell to 6.53 percent, compared to 7.65 percent in the control group, a difference of 1.12 percentage points that persisted even after adjusting for baseline values. Women in the intervention group lost an average of 5.3 kilograms, dropping from 76.25 kg to 70.93 kg, while the control group gained weight. Fasting insulin levels improved, signaling better insulin sensitivity. The lipid profile—cholesterol and triglycerides—shifted favorably in the intervention group and unfavorably in controls. Caloric intake fell by about 168 calories per day in the intervention group, and fiber consumption rose by roughly 16 percent.

The intervention was well tolerated. No serious adverse events occurred. Some women reported mild, temporary headaches, fatigue, constipation, or episodes of low blood sugar as their bodies adjusted. But most reported unexpected benefits: more energy, sharper mental clarity, better appetite control, and a sense of improved well-being. These subjective measures matter because they hint at whether a treatment can become a way of life rather than a burden to endure.

The study has real limitations. The intensive nutritionist support—meal monitoring, regular follow-ups, phone calls—may not be feasible or scalable in many settings. The researchers cannot separate the effects of the diet itself from the fasting protocol from the weight loss from the behavioral support from the simple act of paying closer attention to what one eats. The trial lasted only 24 weeks, leaving the crucial question of long-term sustainability unanswered. The sample was small, drawn from clinics in one city, and included only women, so the findings cannot be generalized to men or to populations in other regions. Women with more severe diabetes—HbA1c above 9 percent—and those on insulin were excluded, narrowing the applicability further.

Yet the core finding stands: for this group of Indian women with type 2 diabetes, a culturally rooted dietary pattern combined with a flexible fasting schedule produced measurable improvements in blood sugar control, weight, and insulin sensitivity over six months. The researchers frame this as evidence that sex-tailored lifestyle interventions deserve continued investigation. The implication is clear: diabetes management cannot be one-size-fits-all. Women face distinct biological and social pressures that shape their ability to manage chronic disease. A treatment that acknowledges those pressures—that uses familiar foods, allows flexibility, and provides human support—may succeed where generic protocols fail. What remains to be seen is whether these benefits persist beyond 24 weeks, and whether the intervention can work without the intensive nutritionist involvement that made this trial possible.